Novartis | NVS - Ordinary Share Capital

Stock Price
150.71
Daily Change
-0.36 -0.24%
Monthly
9.31%
Yearly
42.80%
Q1 Forecast
145.07

Novartis reported $1.92B in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Amgen USD 538M 300K Sep/2025
AstraZeneca USD 1.55B 1.16B Sep/2025
Bausch Health Companies USD 370.47M 723K Sep/2025
Biogen USD 146.7M 200K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Canopy Growth CAD 332.38M 127.23M Sep/2025
Corcept Therapeutics USD 105.12M 164K Sep/2025
Drreddys Laboratories INR 832.57M 53K Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Gilead Sciences USD 1.24B 0 Sep/2025
GlaxoSmithKline GBP 4.03B 119.13M Sep/2025
Glaxosmithkline GBP 4.03B 2.68B Sep/2025
J&J USD 2.41B 584K Sep/2025
Merck USD 2.5B 715.14M Jun/2025
Novartis USD 1.94B 23.4M Jun/2025
Novartis USD 1.92B 17.06M Sep/2025
Pacira USD 44.9M 44.85M Jun/2025
Perrigo USD 137.6M 0 Sep/2025
Pfizer USD 5.69B 1000K Sep/2025
Prestige Brands USD 48.08M 47.52M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Supernus Pharmaceuticals USD 57.12M 1000K Sep/2025
Zoetis USD 441.46M 2.48M Sep/2025